HIV Breakthrough Drug Faces Rollout Hurdles in Uganda

Lenacapavir, a twice-yearly HIV prevention injection, shows unprecedented efficacy in Uganda trials. However, rollout faces criticism over limited access, high costs, and funding cuts, leaving many communities vulnerable despite the drug's promise.